Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Cultured Bone Marrow Tissue

Cell therapy · developed by Vericel

Phase 1/2 Most advanced trial (none active)
VCEL Developer
1 Registered trials

What is Cultured Bone Marrow Tissue?

Cultured Bone Marrow Tissue is a cell-based preparation of bone marrow tissue grown in culture. It is studied in patients with ununited fractures and pseudarthrosis, conditions in which a broken bone fails to heal.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Cell therapy
Therapy area
Musculoskeletal
Developer
Vericel Corporation (VCEL)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00424567 Phase 1/2 Fracture, Ununited Terminated VCEL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Fracture, UnunitedPseudarthrosis

More from Vericel

Follow VCEL, the company behind Cultured Bone Marrow Tissue

See VCEL's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

VCEL catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.